Trial Profile
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized Subjects With Influenza A Infection Who Are at Risk of Developing Complications
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2022
Price :
$35
*
At a glance
- Drugs Pimodivir (Primary) ; Antivirals
- Indications Influenza A virus infections
- Focus Registrational; Therapeutic Use
- Acronyms DIAMOND
- Sponsors Janssen Research & Development; Janssen-Cilag
- 09 Oct 2020 This trial has been completed in the United Kingdom, according to European Clinical Trials Database record.
- 04 Oct 2020 This trial has been discontinued in Sweden, according to European Clinical Trials Database record.
- 15 Sep 2020 This trial has been completed in Estonia, according to European Clinical Trials Database record.